Kyle Elmer Pfeifer MD, Presenter: Nothing to Disclose

Vivek Bihari Kalra MD, Abstract Co-Author: Nothing to Disclose

Brian Haas MD, Abstract Co-Author: Nothing to Disclose

Adebowale Adeniran MD, Abstract Co-Author: Nothing to Disclose

Myung Soo Shin MD, DSc, Abstract Co-Author: Nothing to Disclose

1. Thoracic fungal disease result in significant morbidity and mortality and can be best classified according to patient immune status. 2. We discuss how the appropriate diagnosis of thoracic fungl disease is important for patient care/prognosis. 3. We review the pathophysiology and radiographic findings of thoracic fungal disease in immunocompetent hosts, focusing on geographic location, as well as implications for treatment and prognosis 4. We review the pathophysiology and radiographic findings of thoracic fungal disease in the immunocompromised host, focusing on implications for patient care.

We describe the prevalence, imaging features, pathological characteristics of common thoracic fungal pathogens, dividing  pathogens into opportunistic and endemic categories. Common opportunistic fungal pathogens include Aspergillus, Candida, Cryptococcus, Pneumocystis, and Mucor. Prompt recognition of disease is important for patient morbidity and mortality and can be difficult in the immunocmpromised host. We then focus on the radiographic and pathologic appearance of common endemic fungal pathogens such as Histoplasma, Coccidioides, Blastomycosis, and Paracocciodiomycosis which have a specific geographic distribution, and discuss the importance of recognizing thoracic fungal infections as it pertains to patient care.

http://abstract.rsna.org/uploads/2014/14001916/14001916_7pck.pdf

Pfeifer, K, Kalra, V, Haas, B, Adeniran, A, Shin, M, Radiologic and Pathologic Manifestations of Thoracic Fungal Disease in the Immunocompetent and Immunocompromised Hosts.  Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL. http://archive.rsna.org/2014/14001916.html